UY26964A1 - DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE - Google Patents

DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE

Info

Publication number
UY26964A1
UY26964A1 UY26964A UY26964A UY26964A1 UY 26964 A1 UY26964 A1 UY 26964A1 UY 26964 A UY26964 A UY 26964A UY 26964 A UY26964 A UY 26964A UY 26964 A1 UY26964 A1 UY 26964A1
Authority
UY
Uruguay
Prior art keywords
erythromycin
derivatives
replaced
gastrointestinal tolerance
greater gastrointestinal
Prior art date
Application number
UY26964A
Other languages
Spanish (es)
Inventor
Zhenkun Ma
Souming Zhang
Ly Tam Phan
Stevan Djuric
Rick F Clark
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY26964A1 publication Critical patent/UY26964A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Compuestos de fórmula I son útiles para el tratamiento de infeciones bacterianas pero sin producir el efecto colateral de intolerancia gastrointestinal. También se revelan composiciones que contienen los compuestos y métodos de tratamiento que los utilizan.Compounds of formula I are useful for the treatment of bacterial infections but without producing the side effect of gastrointestinal intolerance. Compositions containing the compounds and methods of treatment that use them are also disclosed.

UY26964A 2000-10-16 2001-10-12 DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE UY26964A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24077700P 2000-10-16 2000-10-16

Publications (1)

Publication Number Publication Date
UY26964A1 true UY26964A1 (en) 2002-06-20

Family

ID=22907903

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26964A UY26964A1 (en) 2000-10-16 2001-10-12 DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE

Country Status (9)

Country Link
EP (1) EP1328534A2 (en)
JP (1) JP2004529857A (en)
AU (1) AU2002213267A1 (en)
BR (1) BR0109946A (en)
CA (1) CA2420012A1 (en)
MX (1) MXPA03003311A (en)
PE (1) PE20020522A1 (en)
UY (1) UY26964A1 (en)
WO (1) WO2002032919A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
JP2005529143A (en) * 2002-04-30 2005-09-29 アボット・ラボラトリーズ Antibacterial compounds with improved pharmacokinetic profiles
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
WO2004078771A1 (en) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. 2-fluoro-6-o-substituted ketolide derivative
JP2007223900A (en) * 2004-02-03 2007-09-06 Taisho Pharmaceut Co Ltd 6-o-substituted ketolide derivative
JP2007254285A (en) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd 2-fluoro-6-o-substituted ketolide derivative
EP1985620A4 (en) 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd 10a-AZALIDE COMPOUND
WO2009019868A1 (en) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. 10a-azalide compound crosslinked at position-10a and position-12
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
CN102234302B (en) * 2010-05-07 2014-05-07 北京理工大学 Novel ketolide derivatives, and preparation method and medicinal compositions thereof
AR085286A1 (en) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd MACROLIDO DERIVATIVE REPLACED IN POSITION C-4
AR102810A1 (en) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd MACROLID DERIVATIVE REPLACED IN POSITION C-4

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Also Published As

Publication number Publication date
CA2420012A1 (en) 2002-04-25
BR0109946A (en) 2005-08-02
JP2004529857A (en) 2004-09-30
MXPA03003311A (en) 2003-09-10
WO2002032919A2 (en) 2002-04-25
WO2002032919A3 (en) 2002-09-19
AU2002213267A1 (en) 2002-04-29
EP1328534A2 (en) 2003-07-23
PE20020522A1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
ECSP003699A (en) FAB I INHIBITORS
ATE376996T1 (en) ANTIBACTERIAL AGENTS
NO20025954D0 (en) Glykopeptidfosfonatderivater
PA8527001A1 (en) USEFUL POLYARILCARBOXAMIDS AS LIPID REDUCING AGENTS
UY26964A1 (en) DERIVATIVES OF ERYTHROMYCIN 6-0-REPLACED WITH GREATER GASTROINTESTINAL TOLERANCE
TR200101126T2 (en) Substituted phenyl derivatives, their preparation and uses
DE60135919D1 (en) FARNESYL TRANSFERASE-INHIBITING 6-HETEROCYCLYLMETHYL-CHINOLINE AND CHINAZOLE DERIVATIVES
CY1107789T1 (en) ANTHELMINTHICAL COMPOSITIONS CONTAINING ABMERTEIN OR MILBEMYKIN COMPOSITIONS AFTER DISCOVERY COMPOUNDS
ATE433963T1 (en) FAB-I INHIBITORS
IS8334A (en) Antineoplastic compositions consisting of defibrotide single or mixed with other antineoplastic agents
DE60121345D1 (en) ALKYLATED IMIDAZOPYRIDINE DERIVATIVES
DK1643984T3 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
DK1313740T3 (en) Prodrugs of imidazopyridine derivatives
DE60127131D1 (en) TRICYCLIC IMIDAZOPYRIDINE
ECSP034598A (en) LACTAMIC COMPOUND
ATE259813T1 (en) TRIAZOLOPYRIMIDE DERIVATIVES
BRPI0412446A (en) silicon compounds and their use
DE60304360D1 (en) N-ARYL-2-OXAZOLIDINONE AND DERIVATIVES
PA8486101A1 (en) HYGROMYCIN DERIVATIVES
CY1110139T1 (en) GLYPOPEIDIC ANTIBODIES
ATE425984T1 (en) TRICYCLIC ANTIBACTERIAL MACROLIDE DERIVATIVES
GT199600061A (en) PROFARMACOS POLIMORFOS DE 6-N- (L-ALA-L-ALA) -TROVAFLOXACINA.
ATE478155T1 (en) GLYCOPEPTIDE ANTIBIOTIC
AR023780A1 (en) CETOLID ANTIBACTERIALS
ECSP003536A (en) RUFOMYCIN DERIVATIVES USEFUL AS ANTIBIOTICS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126